Vancouver, British Columbia--(Newsfile Corp. - December 16, 2021) - Resverlogix Corp. (TSX: RVX) - Donald McCaffrey, President & CEO speaks about the late-stage biotechnology company and their flagship drug - Apabetalone.

Cannot view this video? Visit:https://b-tv.com/resverlogix-the-future-of-drug-development-btv-investing-news/

Resverlogix...